CFO
ABBV icon

Collective Family Office’s AbbVie ABBV Stock Holding History

Collective Family Office’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.14M Sell
4,360
-146
-3% -$37.4K 0.24% 72
2026
Q2 		$1.13M Sell
4,506
-166
-4% -$35.7K 0.23% 74
2026
Q1 		$1.02M Sell
4,672
-750
-14% -$166K 0.23% 72
2025
Q4 		$1.24M Sell
5,422
-134
-2% -$30.5K 0.28% 69
2025
Q3 		$1.29M Sell
5,556
-38
-0.7% -$7.74K 0.31% 65
2025
Q2 		$1.04M Sell
5,594
-303
-5% -$56.3K 0.27% 74
2025
Q1 		$1.24M Sell
5,897
-438
-7% -$85.1K 0.33% 61
2024
Q4 		$1.13M Sell
6,335
-252
-4% -$46.3K 0.31% 65
2024
Q3 		$1.3M Sell
6,587
-243
-4% -$45.4K 0.35% 61
2024
Q2 		$1.17M Sell
6,830
-120
-2% -$19.9K 0.34% 67
2024
Q1 		$1.27M Sell
6,950
-174
-2% -$30K 0.41% 55
2023
Q4 		$1.1M Sell
7,124
-85
-1% -$12.4K 0.39% 59
2023
Q3 		$1.07M Sell
7,209
-705
-9% -$103K 0.42% 58
2023
Q2 		$1.07M Sell
7,914
-575
-7% -$84.3K 0.42% 57
2023
Q1 		$1.35M Sell
8,489
-390
-4% -$59.6K 0.56% 48
2022
Q4 		$1.43M Sell
8,879
-1,804
-17% -$277K 0.64% 45
2022
Q3 		$1.43M Sell
10,683
-2,954
-22% -$424K 0.71% 41
2022
Q2 		$2.09M Buy
13,637
+646
+5% +$98.7K 0.9% 34
2022
Q1 		$2.11M Sell
12,991
-2,557
-16% -$371K 0.8% 38
2021
Q4 		$2.1M Sell
15,548
-1,391
-8% -$164K 0.83% 35
2021
Q3 		$1.83M Buy
16,939
+4
+0% +$457 0.79% 34
2021
Q2 		$1.91M Sell
16,935
-899
-5% -$101K 0.82% 34
2021
Q1 		$1.93M Buy
17,834
+1,777
+11% +$190K 0.94% 33
2020
Q4 		$1.72M Buy
+16,057
New +$1.54M 0.96% 29

Other funds holding ABBV

HCM
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Collective Family Office's ABBV Position: Q3 2026 in Review

Collective Family Office reduced its AbbVie (ABBV) stake by 3.2% in Q3 2026, selling an estimated $37.4K and leaving 4,360 shares worth $1.14M. The position accounts for 0.24% of the portfolio, ranked #72.

Collective Family Office first reported a position in ABBV in Q4 2020 and has held it in 24 quarters since. The position peaked at $2.11M in Q1 2022. 246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Collective Family Office held 4,360 shares of AbbVie worth $1.14M as of Q3 2026.
  • Collective Family Office sold 146 AbbVie shares in Q3 2026, an estimated $37.4K.
  • AbbVie made up 0.24% of Collective Family Office's portfolio in Q3 2026, its #72 holding.
  • Collective Family Office first reported a position in AbbVie in Q4 2020 and has held it in 24 quarters since.
  • Collective Family Office's AbbVie position peaked at $2.11M in Q1 2022.
  • 246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Collective Family Office's 13F filing for Q3 2026, filed 5 Oct 2026.